Plain-English translation of NCT06087614 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
DE-HyART is a research study testing a new approach to treating head and neck squamous cell carcinoma. The trial uses a special imaging scan to identify areas of your tumor that have low oxygen levels, then delivers extra radiation doses to those specific spots while giving standard chemotherapy. The goal is to see if this targeted approach helps control cancer better than standard treatment alone.
Low-oxygen areas in tumors are often resistant to radiation therapy and can make cancer harder to cure. This trial explores whether identifying and intensifying treatment to these challenging areas can improve long-term cancer control without causing unacceptable side effects.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will first undergo a special imaging scan to measure oxygen levels in your tumor. Depending on the results, you may be assigned to one of three groups: standard treatment (if your tumor has normal oxygen), standard dose radiation with chemotherapy, or standard dose radiation plus an extra boost of radiation to low-oxygen areas. Treatment involves daily radiation visits over several weeks combined with chemotherapy given periodically. Your care team will monitor you closely throughout and after treatment to assess how well the cancer responds and manage any side effects.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
India